Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells

doi:10.1084/jem.177.6.1541

This Article

	Full Text (PDF, 996K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Jameson, S. C.
	Articles by Bevan, M. J.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Jameson, S. C.
	Articles by Bevan, M. J.


Social Bookmarking

	What's this?

ARTICLES

Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells

SC Jameson, FR Carbone and MJ Bevan
Howard Hughes Medical Institute, Department of Immunology, University of Washington, Seattle 98195.

A previous report showed that the proliferative response of helper T cells to class II major histocompatibility complex (MHC)-restricted antigens can be inhibited by analogues of the antigen, which act as T cell receptor (TCR) antagonists. Here we define and analyze peptide variants that antagonize various functions of class I MHC-restricted cytotoxic T lymphocyte (CTL) clones. Of 64 variants at individual TCR contact sites of the Kb-restricted octamer peptide ovalbumin257-264 (OVAp), a very high proportion (40%) antagonized lysis by three OVAp- specific CTL clones. This effect was highly clone specific, since many antagonists for one T cell clone have differential effects on another. We show that this inhibition of CTL function is not a result of T cell- T cell interaction, precluding veto-like phenomena as a mechanism for antagonism. Moreover, we present evidence for direct interaction between the TCR and antagonist-MHC complexes. In further analysis of the T cell response, we found that serine esterase release and cytokine production are susceptible to TCR antagonism similarly to lysis. Ca2+ flux, an early event in signaling, is also inhibited by antagonists but may be more resistant to the antagonist effect than downstream responses.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Apte, S. H., Baz, A., Groves, P., Kelso, A., Kienzle, N. (2008). Interferon-{gamma} and interleukin-4 reciprocally regulate CD8 expression in CD8+ T cells. Proc. Natl. Acad. Sci. USA 105: 17475-17480 [Abstract] [Full Text]
Mareeva, T., Martinez-Hackert, E., Sykulev, Y. (2008). How a T Cell Receptor-like Antibody Recognizes Major Histocompatibility Complex-bound Peptide. J. Biol. Chem. 283: 29053-29059 [Abstract] [Full Text]
Jones, D. S., Reichardt, P., Ford, M. L., Edwards, L. J., Evavold, B. D. (2008). TCR Antagonism by Peptide Requires High TCR Expression. J. Immunol. 181: 1760-1766 [Abstract] [Full Text]
Hommel, M., Hodgkin, P. D. (2007). TCR Affinity Promotes CD8+ T Cell Expansion by Regulating Survival. J. Immunol. 179: 2250-2260 [Abstract] [Full Text]
Webb, A. I., Dunstone, M. A., Williamson, N. A., Price, J. D., de Kauwe, A., Chen, W., Oakley, A., Perlmutter, P., McCluskey, J., Aguilar, M.-I., Rossjohn, J., Purcell, A. W. (2005). T Cell Determinants Incorporating {beta}-Amino Acid Residues Are Protease Resistant and Remain Immunogenic In Vivo. J. Immunol. 175: 3810-3818 [Abstract] [Full Text]
Ely, L. K., Green, K. J., Beddoe, T., Clements, C. S., Miles, J. J., Bottomley, S. P., Zernich, D., Kjer-Nielsen, L., Purcell, A. W., McCluskey, J., Rossjohn, J., Burrows, S. R. (2005). Antagonism of Antiviral and Allogeneic Activity of a Human Public CTL Clonotype by a Single Altered Peptide Ligand: Implications for Allograft Rejection. J. Immunol. 174: 5593-5601 [Abstract] [Full Text]
Mareeva, T., Lebedeva, T., Anikeeva, N., Manser, T., Sykulev, Y. (2004). Antibody Specific for the Peptide{middle dot}Major Histocompatibility Complex: IS IT T CELL RECEPTOR-LIKE?. J. Biol. Chem. 279: 44243-44249 [Abstract] [Full Text]
McKinney, D. M., Skvoretz, R., Livingston, B. D., Wilson, C. C., Anders, M., Chesnut, R. W., Sette, A., Essex, M., Novitsky, V., Newman, M. J. (2004). Recognition of Variant HIV-1 Epitopes from Diverse Viral Subtypes by Vaccine-Induced CTL. J. Immunol. 173: 1941-1950 [Abstract] [Full Text]
Santori, F. R., Holmberg, K., Ostrov, D., Gascoigne, N. R. J., Vukmanovic, S. (2004). Distinct Footprints of TCR Engagement with Highly Homologous Ligands. J. Immunol. 172: 7466-7475 [Abstract] [Full Text]
Starr, T. K., Daniels, M. A., Lucido, M. M., Jameson, S. C., Hogquist, K. A. (2003). Thymocyte Sensitivity and Supramolecular Activation Cluster Formation Are Developmentally Regulated: A Partial Role for Sialylation. J. Immunol. 171: 4512-4520 [Abstract] [Full Text]
Huseby, E. S., Crawford, F., White, J., Kappler, J., Marrack, P. (2003). Negative selection imparts peptide specificity to the mature T cell repertoire. Proc. Natl. Acad. Sci. USA 100: 11565-11570 [Abstract] [Full Text]
Karlsson, A. C., Deeks, S. G., Barbour, J. D., Heiken, B. D., Younger, S. R., Hoh, R., Lane, M., Sallberg, M., Ortiz, G. M., Demarest, J. F., Liegler, T., Grant, R. M., Martin, J. N., Nixon, D. F. (2003). Dual Pressure from Antiretroviral Therapy and Cell-Mediated Immune Response on the Human Immunodeficiency Virus Type 1 Protease Gene. J. Virol. 77: 6743-6752 [Abstract] [Full Text]
Yang, W., Grey, H. M. (2003). Study of the Mechanism of TCR Antagonism Using Dual-TCR-Expressing T Cells. J. Immunol. 170: 4532-4538 [Abstract] [Full Text]
Hommel, M., Kyewski, B. (2003). Dynamic Changes During the Immune Response in T Cell-Antigen-presenting Cell Clusters Isolated from Lymph Nodes. JEM 197: 269-280 [Abstract] [Full Text]
Singh, R. A. K., Rodgers, J. R., Barry, M. A. (2002). The Role of T Cell Antagonism and Original Antigenic Sin in Genetic Immunization. J. Immunol. 169: 6779-6786 [Abstract] [Full Text]
McMahon, C. W., Zajac, A. J., Jamieson, A. M., Corral, L., Hammer, G. E., Ahmed, R., Raulet, D. H. (2002). Viral and Bacterial Infections Induce Expression of Multiple NK Cell Receptors in Responding CD8+ T Cells. J. Immunol. 169: 1444-1452 [Abstract] [Full Text]
den Haan, J. M. M., Mutis, T., Blokland, E., IJzerman, A. P., Goulmy, E. (2002). General T-cell receptor antagonists to immunomodulate HLA-A2-restricted minor histocompatibility antigen HA-1-specific T-cell responses. Blood 99: 985-992 [Abstract] [Full Text]
Santori, F. R., Brown, S. M., Lu, Y., Neubert, T. A., Vukmanovic, S. (2001). Cutting Edge: Positive Selection Induced by a Self-Peptide with TCR Antagonist Activity. J. Immunol. 167: 6092-6095 [Abstract] [Full Text]
Lopez, D., Samino, Y., Koszinowski, U. H., Del Val, M. (2001). HIV Envelope Protein Inhibits MHC Class I Presentation of a Cytomegalovirus Protective Epitope. J. Immunol. 167: 4238-4244 [Abstract] [Full Text]
Lieberman, J., Shankar, P., Manjunath, N., Andersson, J. (2001). Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood 98: 1667-1677 [Abstract] [Full Text]
Hudrisier, D., Riond, J., Gairin, J. E. (2001). Molecular and Functional Dissection of the H-2Db-Restricted Subdominant Cytotoxic T-Cell Response to Lymphocytic Choriomeningitis Virus. J. Virol. 75: 2468-2471 [Abstract] [Full Text]
Suzuki, I., Martin, S., Boursalian, T. E., Beers, C., Fink, P. J. (2000). Fas Ligand Costimulates the In Vivo Proliferation of CD8+ T Cells. J. Immunol. 165: 5537-5543 [Abstract] [Full Text]
Garcia-Peydro, M., Paradela, A., Albar, J. P., Castro, J. A. L. d. (2000). Antagonism of Direct Alloreactivity of an HLA-B27-Specific CTL Clone by Altered Peptide Ligands of Its Natural Epitope. J. Immunol. 165: 5680-5685 [Abstract] [Full Text]
Voeten, J. T. M., Bestebroer, T. M., Nieuwkoop, N. J., Fouchier, R. A. M., Osterhaus, A. D. M. E., Rimmelzwaan, G. F. (2000). Antigenic Drift in the Influenza A Virus (H3N2) Nucleoprotein and Escape from Recognition by Cytotoxic T Lymphocytes. J. Virol. 74: 6800-6807 [Abstract] [Full Text]
Kalergis, A. M., Nathenson, S. G. (2000). Altered Peptide Ligand-Mediated TCR Antagonism Can Be Modulated by a Change in a Single Amino Acid Residue Within the CDR3{beta} of an MHC Class I-Restricted TCR. J. Immunol. 165: 280-285 [Abstract] [Full Text]
Kubota, R., Soldan, S. S., Martin, R., Jacobson, S. (2000). An Altered Peptide Ligand Antagonizes Antigen-Specific T Cells of Patients with Human T Lymphotropic Virus Type I-Associated Neurological Disease. J. Immunol. 164: 5192-5198 [Abstract] [Full Text]
Daniels, M. A., Jameson, S. C. (2000). Critical Role for CD8 in T Cell Receptor Binding and Activation by Peptide/Major Histocompatibility Complex Multimers. JEM 191: 335-346 [Abstract] [Full Text]
Hudrisier, D., Riond, J., Mazarguil, H., Oldstone, M. B. A., Gairin, J. E. (1999). Genetically Encoded and Post-translationally Modified Forms of a Major Histocompatibility Complex Class I-restricted Antigen Bearing a Glycosylation Motif Are Independently Processed and Co-presented to Cytotoxic T Lymphocytes. J. Biol. Chem. 274: 36274-36280 [Abstract] [Full Text]
Preckel, T., Fung-Leung, W., Cai, Z., Vitiello, A., Salter-Cid, L., Winqvist, O., Wolfe, T. G., Herrath, M. V., Angulo, A., Ghazal, P., Lee, J., Fourie, A. M., Wu, Y., Pang, J., Ngo, K., Peterson, P. A., Früh, K., Yang, Y. (1999). Impaired Immunoproteasome Assembly and Immune Responses in PA28/ Mice. Science 286: 2162-2165 [Abstract] [Full Text]
Kersh, E. N., Kersh, G. J., Allen, P. M. (1999). Partially Phosphorylated T Cell Receptor {zeta} Molecules Can Inhibit T Cell Activation. JEM 190: 1627-1636 [Abstract] [Full Text]
Auphan, N., Ghosh, S., Flavell, R. A., Schmitt-Verhulst, A.-M. (1999). Differential Requirements for NF-{kappa}B and AP-1 trans-Activation in Response to Minimal TCR Engagement by a Partial Agonist in Naive CD8 T Cells. J. Immunol. 163: 5219-5227 [Abstract] [Full Text]
Su, R.-C., Kung, S. K.-P., Silver, E. T., Lemieux, S., Kane, K. P., Miller, R. G. (1999). Ly-49CB6 NK Inhibitory Receptor Recognizes Peptide-Receptive H-2Kb 1. J. Immunol. 163: 5319-5330 [Abstract] [Full Text]
Hin, S., Zabel, C., Bianco, A., Jung, G., Walden, P. (1999). Cutting Edge: N-Hydroxy Peptides: A New Class of TCR Antagonists. J. Immunol. 163: 2363-2367 [Abstract] [Full Text]
Saito, N. G., Chang, H.-C., Paterson, Y. (1999). Recognition of an MHC Class I-Restricted Antigenic Peptide Can Be Modulated by para-Substitution of Its Buried Tyrosine Residues in a TCR-Specific Manner. J. Immunol. 162: 5998-6008 [Abstract] [Full Text]
Bansal, P., Mukherjee, P., Basu, S. K., George, A., Bal, V., Rath, S. (1999). MHC Class I-Restricted Presentation of Maleylated Protein Binding to Scavenger Receptors. J. Immunol. 162: 4430-4437 [Abstract] [Full Text]
Daniels, M. A., Schober, S. L., Hogquist, K. A., Jameson, S. C. (1999). Cutting Edge: A Test of the Dominant Negative Signal Model for TCR Antagonism. J. Immunol. 162: 3761-3764 [Abstract] [Full Text]
Busch, D. H., Pamer, E. G. (1999). T Cell Affinity Maturation by Selective Expansion during Infection. JEM 189: 701-710 [Abstract] [Full Text]
Burrows, S. R., Khanna, R., Moss, D. J. (1999). Direct Alloreactivity by Human Cytotoxic T Lymphocytes Can Be Inhibited by Altered Peptide Ligand Antagonism. Blood 93: 1020-1024 [Abstract] [Full Text]
Stotz, S. H., Bolliger, L., Carbone, F. R., Palmer, E. (1999). T Cell Receptor (TCR) Antagonism without a Negative Signal: Evidence from T Cell Hybridomas Expressing Two Independent TCRs. JEM 189: 253-264 [Abstract] [Full Text]
Shotton, D. M., Attaran, A. (1998). Variant antigenic peptide promotes cytotoxic T lymphocyte adhesion to target cells without cytotoxicity. Proc. Natl. Acad. Sci. USA 95: 15571-15576 [Abstract] [Full Text]
Ishikawa, T., Kono, D., Chung, J., Fowler, P., Theofilopoulos, A., Kakumu, S., Chisari, F. V. (1998). Polyclonality and Multispecificity of the CTL Response to a Single Viral Epitope. J. Immunol. 161: 5842-5850 [Abstract] [Full Text]
Davey, G. M., Schober, S. L., Endrizzi, B. T., Dutcher, A. K., Jameson, S. C., Hogquist, K. A. (1998). Preselection Thymocytes Are More Sensitive to T Cell Receptor Stimulation Than Mature T Cells. JEM 188: 1867-1874 [Abstract] [Full Text]
Leggatt, G. R., Hosmalin, A., Pendleton, C. D., Kumar, A., Hoffman, S., Berzofsky, J. A. (1998). The Importance of Pairwise Interactions Between Peptide Residues in the Delineation of TCR Specificity. J. Immunol. 161: 4728-4735 [Abstract] [Full Text]
Hogquist, K. A., Bonnevier, J. L. (1998). Development of Peptide-Selected CD8 T Cells in Fetal Thymic Organ Culture Occurs via the Conventional Pathway. J. Immunol. 161: 3896-3901 [Abstract] [Full Text]
Ghendler, Y., Teng, M.-k., Liu, J.-h., Witte, T., Liu, J., Kim, K. S., Kern, P., Chang, H.-C., Wang, J.-h., Reinherz, E. L. (1998). Differential thymic selection outcomes stimulated by focal structural alteration in peptide/major histocompatibility complex ligands. Proc. Natl. Acad. Sci. USA 95: 10061-10066 [Abstract] [Full Text]
Krebs, S., Lamas, J. R., Poenaru, S., Folkers, G., de Castro, J. A.�L., Seebach, D., Rognan, D. (1998). Substituting Nonpeptidic Spacers for the T Cell Receptor-binding Part of Class I Major Histocompatibility Complex-binding Peptides. J. Biol. Chem. 273: 19072-19079 [Abstract] [Full Text]
Legge, K. L., Min, B., Cestra, A. E., Pack, C. D., Zaghouani, H. (1998). TCR Agonist and Antagonist Exert In Vivo Cross-Regulation When Presented on Igs. J. Immunol. 161: 106-111 [Abstract] [Full Text]
Williams, C. B., Vidal, K., Donermeyer, D., Peterson, D. A., White, J. M., Allen, P. M. (1998). In Vivo Expression of a TCR Antagonist: T Cells Escape Central Tolerance But Are Antagonized in the Periphery. J. Immunol. 161: 128-137 [Abstract] [Full Text]
Hemmer, B., Stefanova, I., Vergelli, M., Germain, R. N., Martin, R. (1998). Relationships Among TCR Ligand Potency, Thresholds for Effector Function Elicitation, and the Quality of Early Signaling Events in Human T Cells. J. Immunol. 160: 5807-5814 [Abstract] [Full Text]
Soares, L. R. B., Orr, P. L., Garovoy, M. R., Benichou, G. (1998). Differential Activation of T Cells by Natural Antigen Peptide Analogues: Influence on Autoimmune and Alloimmune In Vivo T Cell Responses. J. Immunol. 160: 4768-4775 [Abstract] [Full Text]
Liu, C.-P., Crawford, F., Marrack, P., Kappler, J. (1998). T cell positive selection by a high density, low affinity ligand. Proc. Natl. Acad. Sci. USA 95: 4522-4526 [Abstract] [Full Text]
Purbhoo, M. A., Sewell, A. K., Klenerman, P., Goulder, P. J.�R., Hilyard, K. L., Bell, J. I., Jakobsen, B. K., Phillips, R. E. (1998). Copresentation of natural HIV-1 agonist and antagonist ligands fails to induce the T cell receptor signaling cascade. Proc. Natl. Acad. Sci. USA 95: 4527-4532 [Abstract] [Full Text]
Daniel, C., Grakoui, A., Allen, P. M. (1998). Inhibition of an In Vitro CD4+ T Cell Alloresponse Using Altered Peptide Ligands. J. Immunol. 160: 3244-3250 [Abstract] [Full Text]
Mortara, L., Letourneur, F., Gras-masse, H., Venet, A., Guillet, J.-G., Bourgault-Villada, I. (1998). Selection of Virus Variants and Emergence of Virus Escape Mutants after Immunization with an Epitope Vaccine. J. Virol. 72: 1403-1410 [Abstract] [Full Text]
Kessler, B., Hudrisier, D., Cerottini, J.-C., Luescher, I. F. (1997). Role of CD8 in Aberrant Function of Cytotoxic T Lymphocytes. JEM 186: 2033-2038 [Abstract] [Full Text]
O'Herrin, S. M., Lebowitz, M. S., Bieler, J. G., al-Ramadi, B. K., Utz, U., Bothwell, A. L.M., Schneck, J. P. (1997). Analysis of the Expression of Peptide-Major Histocompatibility Complexes Using High Affinity Soluble Divalent T Cell Receptors. JEM 186: 1333-1345 [Abstract] [Full Text]
Brossart, P., Bevan, M. J. (1997). Presentation of Exogenous Protein Antigens on Major Histocompatability Complex Class I Molecules by Dendritic Cells: Pathway of Presentation and Regulation by Cytokines. Blood 90: 1594-1599 [Abstract] [Full Text]
Preckel, T., Grimm, R., Martin, S., Weltzien, H. U. (1997). Altered Hapten Ligands Antagonize Trinitrophenyl-specific Cytotoxic T Cells and Block Internalization of Hapten-specific Receptors. JEM 185: 1803-1813 [Abstract] [Full Text]
Legge, K. L., Min, B., Potter, N. T., Zaghouani, H. (1997). Presentation of a T Cell Receptor Antagonist Peptide by Immunoglobulins Ablates Activation of �T Cells by a Synthetic Peptide or Proteins Requiring Endocytic Processing. JEM 185: 1043-1054 [Abstract] [Full Text]
Kessler, B. M., Bassanini, P., Cerottini, J.-C., Luescher, I. F. (1997). Effects of Epitope Modification on T Cell Receptor-Ligand Binding and Antigen Recognition by Seven H-2Kd-restricted Cytotoxic T Lymphocyte Clones Specific for a Photoreactive Peptide Derivative. JEM 185: 629-640 [Abstract] [Full Text]
Meier, U.-C., Klenerman, P., Griffin, P., James, W., K�ppe, B., Larder, B., McMichael, A., Phillips, R. (1995). Cytotoxic T Lymphocyte Lysis Inhibited by Viable HIV Mutants. Science 270: 1360-1362 [Abstract]
Madrenas, J, Wange, R., Wang, J., Isakov, N, Samelson, L., Germain, R. (1995). Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science 267: 515-518 [Abstract]
Hudrisier, D., Riond, J., Burlet-Schiltz, O., von Herrath, M. G., Lewicki, H., Monsarrat, B., Oldstone, M. B. A., Gairin, J. E. (2001). Structural and Functional Identification of Major Histocompatibility Complex Class I-restricted Self-peptides as Naturally Occurring Molecular Mimics of Viral Antigens. POSSIBLE ROLE IN CD8+ T CELL-MEDIATED, VIRUS-INDUCED AUTOIMMUNE DISEASE. J. Biol. Chem. 276: 19396-19403 [Abstract] [Full Text]